How to Combat ‘Superbug’ Antibiotic Resistance?

Antibiotic resistance is an emerging global health threat. New clues have been identified to counter ‘superbug’ antibiotic resistance.

Highlights:

Antibiotic resistance is becoming an emerging global health threat.
Scientists have discovered a mechanism by which the deadly superbug fights against the antibiotic treatment.
New clues have been identified from the mechanism to counter ‘superbug’ antibiotic resistance.

A molecular mechanism by which the potentially deadly superbug ‘Golden Staph’ fights against the antibiotic treatment has been discovered by a research team from Monash University.

‘Superbugs’ are bacteria which could become resistant to commonly used antibiotics and could become a global health threat. The research team in collaboration with Israel's Weizmann Institute of Science, and the NTU Institute of Structural Biology in Singapore has recently found clues on how to counter the ‘Superbug’ Antibiotic Resistance.

Drug Resistance – Antibiotic or Antimicrobial Resistance
Drug resistance is often a problem in malaria, tuberculosis, HIV, sexually transmitted diseases and hospital acquired diseases. Judicious use of antibiotics can control the problem.

‘New clues have been identified to counter ‘superbug’ antibiotic resistance.’

The study findings were published in the journal mBio.

Changes in the 'Superbug' Identified
A latest generation electron microscope was used to image the superbugs at the molecular level. The changes in the superbugs that have become resistant to most of the antibiotics were identified.

The bacterial samples of antibiotic-resistant Staphylococcus aureus or ‘Golden Staph’ that were taken from a hospital patient were examined. Most of them compared data from a non-resistant strain along with their overseas counterparts.

Antibiotic Resistance: Superbug Infection Claims Life of an American Women
Superbug infected women in the United States died due to antibiotic resistance, reveals study.

The research team even included Shashi Bhushan from NTU, and Zohar Eyal and Nobel Laureate, Professor Ada Yonath from the Weizmann Institute who won the Nobel Prize for Chemistry in 2009.

Monash BDI scientist and lead researcher Dr. Matthew Belousoff, said, "Using the combined data we could rationalize how the bacteria escapes drug treatment by a really important hospital antibiotic and describe in molecular detail how it becomes like a superbug."

Breakthrough: New Drug Identified to Combat Antibiotic Resistance
Antibiotic resistance is one of the biggest threats to global health. A newly designed drug may help to combat antibiotic resistance, reveals study.

Dr. Belousoff, said, "The bacteria mutates or evolves to change the shape of the molecule to which the antibiotic would bind so the drug can no longer fit there."

"Knowing what your enemy is doing is the first step to the next phase of new drug design," he said.

Test your Knowledge on Antibiotic Resistance
Antibiotic resistance is a growing public health concern that has reached gigantic proportions. Antibiotic resistance is a change that occurs in bacteria when they are exposed to antibiotics used to treat infections caused by them. This change makes the antibiotics ineffective and the antibiotic-resistant bacteria become “superbugs”.

"We've developed a technique that others can use that might help us speed up the arms race of antibiotic development."

Antibiotic Resistance
Antibiotics are life-saving drugs prescribed for bacterial infections.The ability of the microbes to resist the drug effects is referred to as Antimicrobial Resistance.

Around 2 million people in the world are infected with bacteria. And around 23,000 people die every year due to infections.

The cost of treatment for patients with drug-resistant infections is higher than the care for patients with nonresistant infections. The new findings will help to counter superbug and treat drug-resistant infections.

References

Matthew J. Belousoff, Zohar Eyal, Mazdak Radjainia, Tofayel Ahmed, Rebecca S. Bamert, Donna Matzov, Anat Bashan, Ella Zimmerman, Satabdi Mishra, David Cameron, Hans Elmlund, Anton Y. Peleg, Shashi Bhushan, Trevor Lithgow, Ada Yonath. Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome. mBio, 2017; 8 (3): e00395-17 DOI: 10.1128/mBio.00395-17
Antimicrobial resistance - (http://www.who.int/mediacentre/factsheets/fs194/en/ )
Antibiotic / Antimicrobial Resistance - (https://www.cdc.gov/drugresistance/)

Source-Medindia